Selecta Biosciences

Selecta Biosciences is a biopharmaceutical company developing first-generation nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Their proprietary product platform technology combines the latest advances in immunobiology with cutting-edge nanotechnology to develop targeted immune-modulating nanoparticles.